DIGITAL EDITION

ARCHIVES

Category: Departments

A message from the chair, ISCTM Scientific Publications

Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM) brings together academic researchers, policy makers, and industry and government representatives to focus on promoting

Translational and Early Phase Strategies for Treatment Development: Report of ISCTM Autumn 2013 Symposium

by Jared W. Young, PhD; William Z. Potter, MD, PhD; Steve Riley, PharmD, PhD; Geert J. Groeneveld, MD, PhD; Bruce J. Kinon, MD; Mike F. Egan, MD; and Douglas E.

Press Release: Concussion Vital Signs Announces Availability of the Concussion Testing Platform at no Cost to All Schools, Colleges, and Universities

Allows all athletes from grade school through college, concussion management continuity, where schools and healthcare providers partner to test at no cost to the school, provider or athlete Research Triangle

Editor’s Message and January-February 2015 Issue Highlights

Dear Colleagues: Welcome to the January-February 2015 issue of Innovations in Clinical Neuroscience and to the beginning of our 12th year of publication. Over the years, we have sought to

Functional Cortical and Cerebellar Reorganization in a Case of Moyamoya Disease

by Rocco S. Calabrò, MD, PhD; Placido Bramanti, MD; Annalisa Baglieri, PsyD, PhD; Francesco Corallo, PsyD; Rosaria De Luca, MSc, PhD; Simona De Salvo, MSc; Silvia Marino, MD, PhD All

Editor’s Message and Issue Highlights: November-December 2014

Dear Colleagues: Welcome to the November–December 2014 issue of Innovations in Clinical Neuroscience. We start this issue with the first of what we hope to be a series of drug

Consensus Recommendations on Rater Training and Certification

by The CNS Summit Rater Training and Certification Committee: Mark D. West; David G. Daniel, MD; Mark Opler, PhD, MPH; Alexandria Wise-Rankovic, PhD; and Amir Kalali, MD Mr. West is

Our Current Understanding of Adult ADHD

by Steven D. Targum and Lenard A. Adler Steven D. Targum, MD, is the scientific director at Clintara LLC, the chief medical officer at Methylation Sciences Inc., BrainCells Inc., and